All In Biotech

Free tool

FAERS Monitor: Tadliq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214522 or its brand name (Tadliq, Tadalafil). Reports on generic versions are filed under their own applications.

Reports

32,516

Serious

21,489

66% of reports

Hospitalization

12,806

Death reported

3,167

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea4,261
  • headache3,819
  • diarrhoea3,154
  • nausea2,569
  • fatigue2,536
  • cough2,047
  • dizziness1,957
  • death1,528
  • off label use1,355
  • vomiting1,330
  • drug ineffective1,276
  • pneumonia1,255
  • pain1,233
  • hypotension1,186
  • malaise1,148

Reports by year received

View as table
YearReports
200424
200513
200615
200737
200826
200943
201081
2011185
2012120
2013165
2014213
2015257
2016431
2017408
2018972
20192,934
20202,680
20212,876
20223,544
20234,261
20244,578
20255,104
20263,549

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,643 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dyspnoeaSignal4,2614.94.813,478
coughSignal2,0474.74.66,091
headacheSignal3,8194.03.88,646
hypotensionSignal1,1863.83.62,499
diarrhoeaSignal3,1543.23.14,811
dizzinessSignal1,9572.52.41,870
pneumoniaSignal1,2552.52.41,155
fatigueSignal2,5362.12.01,533
nauseaSignal2,5692.12.01,539
vomiting1,3301.81.7512
malaise1,1481.71.6332
pain1,2331.31.287
death1,5281.11.130
off label use1,3551.01.00
drug ineffective1,2760.60.6304

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.